Vaccine was generally well-tolerated with only a few mild side-effects reported
News
Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial
Company expect to file regulatory submissions in 2021
Pharma’s reputation has climbed during COVID-19 pandemic, study finds
Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings
AstraZeneca forges licensing agreement with Redx Pharma
AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset
NHS adapts to pandemic with ‘COVID-friendly’ cancer treatments
Health service extends access to at-home treatments to reduce patients’ risk of contracting coronavirus
Janssen’s depression nasal spray Spravato bags new FDA approval
Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour
Oxford Biomedica and Beam Therapeutics sign CAR-T deal
Agreement will utilise Oxford Biomedica’s LentiVector platform
Roche’s tumour-agnostic therapy Rozlytrek approved in EU
Therapy has been approved to treat advanced NTRK fusion-positive solid tumours
UK increases COVID-19 vaccine manufacturing capacity
New deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage
Immodulon, Champalimaud Foundation team up on ‘difficult to treat’ cancers
Collaboration will explore experimental treatment IMM-101 in combination with other therapies in advanced cancers
Cosentyx wins EU approval for first-line paediatric psoriasis
Low-dose and high-dose Cosentyx is effective in rapidly improving skin symptoms and quality of life
Genmab/Janssen’s Darzalex combo hits the mark in phase 3 study
Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint
Sanofi, GSK in advanced discussions with EU for COVID-19 vaccine
Supply deal could include up to 300 million doses of vaccine
US expands scope of Janssen’s Stelara
The new approval cover paediatric patients with plaque psoriasis
UK firm starts research on skin patch for COVID vaccines
The patch will be tested to deliver a vaccine dose via the skin, as well as achieve a simple and secure disposal process to enable at-home use.
